Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00754494Phase 2Completed
Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
Adenomatous PolypRecurrent Colon CancerRecurrent Rectal Cancer+14 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Crystal Denlinger, MD

Fox Chase Cancer Center

Related
3 trials

Shared therapeutic areas:

Stage I Colon CancerStage I Rectal CancerStage IIA Colon Cancer+11 more
Similarity Score25%

Virginia Sun

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Stage I Colon CancerStage I Rectal CancerStage IIA Colon Cancer+11 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score25%

Betty Ferrell

City of Hope Medical Center

Related
5 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Rectal CancerStage IIA Colon Cancer+11 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score25%

Caio Rocha Lima, MD

Wake Forest University Health Sciences

Related
4 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Rectal CancerStage IIIA Colon Cancer+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score14%

Joshua Meyer

Fox Chase Cancer Center

Related
3 trials

Shared therapeutic areas:

Recurrent Rectal CancerStage IIA Rectal CancerStage IIB Rectal Cancer+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Wen Wee Ma

Roswell Park Cancer Institute

Related
5 trials

Shared therapeutic areas:

Stage IIIA Colon CancerStage IIIA Rectal CancerStage IIIB Colon Cancer+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Hedy Kindler

University of Chicago Comprehensive Cancer Center

Related
6 trials

Shared therapeutic areas:

Stage IIIA Colon CancerStage IIIA Rectal CancerStage IIIB Colon Cancer+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

Related
6 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Rectal CancerStage I Colon Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Sanjiv Gambhir, MD, PhD

Stanford University

Related
3 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Rectal Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Antonius Miller

Cancer and Leukemia Group B

Related
3 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Rectal Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00754494Phase 2PrincipalInvestigator

Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma

Adenomatous PolypRecurrent Colon CancerRecurrent Rectal Cancer+14 more
Completed

All 1 trials loaded